RELIEF THERAPEUTICS Holding SA (SIX: RLF; OTCQB: RLFTF, RLFTY) We are a biopharmaceutical company committed to providing therapeutic relief to patients living with rare diseases. Our goal is to advance treatment paradigms and deliver improvements in efficacy, safety and convenience to benefit the lives of patients and their families.
Our therapeutic focus is on rare indications for metabolic disorders, pulmonary diseases, and dermatology/connective tissue disorders.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Campus Biotech, Geneve,1202,switzerland
- co****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://relieftherapeutics.com/
- Keywords
- Acute Lung Injury, Pulmonary Sarcoidosis, Lung Fibrosis, Acute Respiratory Distress Syndrome, Urea Cycle Disorders, Maple Syrup Urine Disease, Rare Diseases, Epidermolysis Bullosa, Phenylketonuria, PKU, EB, MSUD, UCD, ARDS, Rare Disease, Metabolic Disorders, Acute Lung Disease, Chronic Lung Disease.
- HQ
- Geneve
Relief Therapeutics Holding Sa Questions
Relief Therapeutics Holding Sa's website is https://relieftherapeutics.com/
Relief Therapeutics Holding Sa's LinkedIn profile is https://ch.linkedin.com/company/relief-therapeutics-holding-sa
Relief Therapeutics Holding Sa has
8 employees.
View email and phone details for 8
employees at Relief Therapeutics Holding Sa.
Relief Therapeutics Holding Sa's industry is
Biotechnology Research
Relief Therapeutics Holding Sa's top competitors are
Release Therapeutics,
Altamira Therapeutics,
Apr Applied Pharma Research S.a.,
Relief Therapies,
Lugano,
Demosquare,
Addex Therapeutics,
Calingo Insurance Ag,
Eton Pharmaceuticals,
Zevra Therapeutics.
Relief Therapeutics Holding Sa's support email address is contact@relieftherapeutics.com
Relief Therapeutics Holding Sa's categories are Biotechnology Research
Relief Therapeutics Holding Sa's founding year is 2013
